Francesca Barone
CIK 1909680 · View on SEC EDGAR ↗
First SEC filing: Feb. 7, 2022 · Latest: Feb. 7, 2022
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 29, 2026 | CADL | S 10b5-1 | 23,447 | $10.06 | $235,877 | 77,362 Direct | -23.26% | Disposed | 26.6% (price as of 2026-08-19) |
| March 18, 2025 | CADL | S 10b5-1 | 32,146 | $8.76 | $281,599 | 96,527 Direct | -24.98% | Disposed | 45.4% (price as of 2026-08-19) |
| Jan. 15, 2025 | CADL | S | 13,534 | $7.22 | $97,715 | 110,673 Direct | -10.90% | Disposed | 76.5% (price as of 2026-08-19) |
| Jan. 8, 2025 | CADL | S | 13,673 | $8.22 | $112,392 | 124,207 Direct | -9.92% | Disposed | 55.0% (price as of 2026-08-19) |
| Nov. 29, 2024 | CADL | S | 22,081 | $4.56 | $100,689 | 137,880 Direct | -13.80% | Disposed | 179.4% (price as of 2026-08-19) |
| July 17, 2024 | CADL | S | 14,051 | $6.47 | $90,910 | 159,961 Direct | -8.07% | Disposed | 96.9% (price as of 2026-08-19) |
| July 11, 2024 | CADL | S | 12,645 | $5.97 | $75,491 | 174,012 Direct | -6.77% | Disposed | 113.4% (price as of 2026-08-19) |
| Dec. 8, 2022 | CADL | P | 1,238 | $1.61 | $1,993 | 2,738 Direct | +82.53% | Acquired | 691.3% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | CADL | Stock Option (Right to Buy) | Common Stock (232,000) | $6.01 | Jan. 26, 2036 | 232,000 | Acquired |
| March 18, 2025 | CADL | Stock Option (Right to Buy) | Common Stock (18,000) | $1.55 | Dec. 30, 2030 | 18,000 | Disposed |
| Feb. 12, 2025 | CADL | Stock Option (Right to Buy) | Common Stock (115,000) | $8.55 | Feb. 12, 2035 | 115,000 | Acquired |
| April 28, 2023 | CADL | Stock Option (Right to Biuy) | Common Stock (90,000) | $1.29 | April 28, 2033 | 90,000 | Acquired |
| Feb. 28, 2022 | CADL | Stock Option (Right to Buy) | Common Stock (110,000) | $4.12 | Feb. 28, 2032 | 110,000 | Acquired |
| Feb. 3, 2022 | CADL | Stock Option (Right to Buy) | Common Stock (40,000) | $4.06 | Feb. 3, 2032 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CADL
M.D.,Ph.D.Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $483,312 | — | — | — | $206,427 | — | $14,000 | $1,561,536 |
| 2024 | $443,303 | — | — | — | $269,119 | — | $13,800 | $726,222 |
| 2023 | $413,005 | — | — | — | $80,560 | — | $13,200 | $706,876 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.